Figure 1. Profiling of immune cell subsets of patients with T2DN. (A) Gating strategies for peripheral blood immune cells. Proportions of (B) M-, PMN-, and Lox-1⁺ PMN-MDSCs, (C) total, CD4⁺, and CD8⁺ T cells, (D) regulatory and NK T cells, (E) B and NK cells, and monocytes in patients and healthy individuals.

^*p<0.05; ^**p<0.01; ^***p<0.001.